Aurobindo Pharma Limited tumbles 7% on muted Q4

Aurobindo Pharma fell as much as 7.45% on early Tuesday on muted quarterly numbers. The drug firm on Monday reported a marginal decline in its net profit at Rs 528.5 crore for the fourth quarter to March 2018.

Its net profit read Rs 532.5 crore in the previous fiscal. Revenue from operations, however, rose to Rs 4,049.1 crore for January-March, compared with Rs 3,641.6 crore earlier, Aurobindo Pharma said in a regulatory filing.

For more information and best STOCK TIPS Call us ✆ – 0731-6642300 or Visit http://www.epicresearch.co

Connect with our social media sites

Facebook

Twitter

YouTube

Pinterest

Linkedin

Google+

Follow @Epic_Research